Medical Home Fails to Prove Quality, Cost Claims

Although highly touted, the patient-centered medical home model failed to lower use of services or total costs and produced little quality improvement over three years, research has found.
Published Online: February 28, 2014
Although highly touted, the patient-centered medical home model failed to lower use of services or total costs and produced little quality improvement over three years, research in the latest Journal of the American Medical Association (JAMA) has found.

However, a number of factors may account for the findings and suggest that medical homes may need “further refinement.”

The research tracked the southeastern Pennsylvania Chronic Care Initiative in one of the first, largest and longest-running multi-payer trials of the team-based model from 2008 to 2011. The pilot included 32 primary care practices with recognition from the National Committee for Quality Assurance (NCQA) and six health plans, with two commercial and two Medicaid plans supplying claims data.

Medical home efforts have encouraged primary providers to invest in patient registries, use electronic medication prescribing, enhanced access options and other structural changes aimed at improving patient care in exchange for bonuses.

Read the full story here: http://bit.ly/NCReps

Source: Healthcare Payer News



Feature
Recommended Articles
Christine K. Cassel, MD, president and CEO of the National Quality Forum, sent her best wishes to The American Journal of Managed Care for its 20th year anniversary in publication.
The world of value-based purchasing needs to quickly adopt the use of electronic health records and their ability to share data around a single patient, according to Christine K. Cassel, MD, president and CEO of the National Quality Forum.
California’s recent initiatives to address the impact of high priced hepatitis C drugs could not have come at a better time, as a new analysis estimates that the state’s projected specialty drug expenditure would be $4.77 billion in the next year alone.
Aetna's purchase of Humana would create a managed care company with $115 billion in revenues, of which 56% would be from government business. In addition, the combined company would have the largest enrollment of members on public exchanges, with 1.7 million members.
Scott Gottlieb, MD, and Ted Okon, MBA, discuss controversies surrounding a proposed legislative amendment that would allow the government to negotiate drug pricing with pharmaceutical companies.